vs
Side-by-side financial comparison of INNO HOLDINGS INC. (INHD) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Instil Bio, Inc. is the larger business by last-quarter revenue ($2.2M vs $1.5M, roughly 1.5× INNO HOLDINGS INC.). INNO HOLDINGS INC. runs the higher net margin — -2.0% vs -365.3%, a 363.4% gap on every dollar of revenue. On growth, INNO HOLDINGS INC. posted the faster year-over-year revenue change (635.6% vs -19.2%).
INNOvative Retail BV, is an upmarket Belgian department store chain that operates sixteen branches around Belgium.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
INHD vs TIL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.5M | $2.2M |
| Net Profit | $-28.6K | $-8.2M |
| Gross Margin | 5.1% | — |
| Operating Margin | -33.4% | -426.3% |
| Net Margin | -2.0% | -365.3% |
| Revenue YoY | 635.6% | -19.2% |
| Net Profit YoY | 95.3% | 31.1% |
| EPS (diluted) | $-0.01 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5M | $2.2M | ||
| Q3 25 | $1.1M | $2.2M | ||
| Q2 25 | $1.1M | $2.2M | ||
| Q1 25 | $478.1K | $2.2M | ||
| Q4 24 | $196.0K | $2.8M | ||
| Q3 24 | $490.0K | $1.5M | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $183.2K | $0 |
| Q4 25 | $-28.6K | $-8.2M | ||
| Q3 25 | $-1.3M | $-13.6M | ||
| Q2 25 | $-1.5M | $-21.4M | ||
| Q1 25 | $-3.6M | $-28.2M | ||
| Q4 24 | $-603.7K | $-11.9M | ||
| Q3 24 | $-287.2K | $-23.0M | ||
| Q2 24 | — | $-14.9M | ||
| Q1 24 | $-1.1M | $-24.3M |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | -1.5% | — | ||
| Q1 25 | 8.7% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -33.4% | -426.3% | ||
| Q3 25 | -89.7% | -670.0% | ||
| Q2 25 | -143.7% | -1045.5% | ||
| Q1 25 | -286.4% | -1363.2% | ||
| Q4 24 | -233.7% | -426.1% | ||
| Q3 24 | 87.7% | -1582.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | -150.9% | — |
| Q4 25 | -2.0% | -365.3% | ||
| Q3 25 | -120.5% | -606.0% | ||
| Q2 25 | -142.4% | -954.2% | ||
| Q1 25 | -757.3% | -1257.8% | ||
| Q4 24 | -308.0% | -428.8% | ||
| Q3 24 | -58.6% | -1541.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | -578.9% | — |
| Q4 25 | $-0.01 | $-1.13 | ||
| Q3 25 | $5.03 | $-2.01 | ||
| Q2 25 | $-0.30 | $-3.24 | ||
| Q1 25 | $-0.83 | $-4.32 | ||
| Q4 24 | $-5.21 | $-1.82 | ||
| Q3 24 | $-0.14 | $-3.54 | ||
| Q2 24 | — | $-2.29 | ||
| Q1 24 | $-0.51 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.1M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $47.2M | $113.9M |
| Total Assets | $47.3M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.1M | $6.6M | ||
| Q3 25 | $10.1M | $5.8M | ||
| Q2 25 | $4.4M | $7.7M | ||
| Q1 25 | $3.9M | $15.4M | ||
| Q4 24 | $4.8M | $8.8M | ||
| Q3 24 | $1.1M | $6.7M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | $4.0M | $5.5M |
| Q4 25 | $47.2M | $113.9M | ||
| Q3 25 | $15.2M | $120.4M | ||
| Q2 25 | $8.0M | $131.7M | ||
| Q1 25 | $7.1M | $144.9M | ||
| Q4 24 | $9.4M | $169.4M | ||
| Q3 24 | $2.8M | $176.3M | ||
| Q2 24 | — | $195.0M | ||
| Q1 24 | $4.1M | $205.8M |
| Q4 25 | $47.3M | $203.5M | ||
| Q3 25 | $16.0M | $211.8M | ||
| Q2 25 | $8.8M | $231.0M | ||
| Q1 25 | $7.3M | $237.4M | ||
| Q4 24 | $10.7M | $263.6M | ||
| Q3 24 | $4.2M | $272.6M | ||
| Q2 24 | — | $294.3M | ||
| Q1 24 | $7.1M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.0M | $-7.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.0M | $-7.1M | ||
| Q3 25 | $-1.0M | $-10.6M | ||
| Q2 25 | $-594.8K | $-14.8M | ||
| Q1 25 | $-1.0M | $-4.2M | ||
| Q4 24 | $-2.1M | $-10.6M | ||
| Q3 24 | $-660.2K | $-20.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | $-2.9M | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-795.1K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-3.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -1083.3% | — | ||
| Q3 24 | -162.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1720.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 13.7% | 0.0% | ||
| Q3 24 | 27.5% | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | 118.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
